Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (12)

2024

  1. Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction

    Antiviral Research, Vol. 231

2023

  1. Abacavir causes leukocyte/platelet crosstalk by activating neutrophil P2X7 receptors thus releasing soluble lectin-like oxidized low-density lipoprotein receptor-1

    British Journal of Pharmacology, Vol. 180, Núm. 11, pp. 1516-1532

2022

  1. Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz

    Biomedicines, Vol. 10, Núm. 1

  2. Role of neutrophil extracellular traps in covid-19 progression: An insight for effective treatment

    Biomedicines, Vol. 10, Núm. 1

2021

  1. Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?

    Frontiers in Pharmacology, Vol. 12

  2. Hypercholesterolemic patients have higher eryptosis and erythrocyte adhesion to human endothelium independently of statin therapy

    International Journal of Clinical Practice, Vol. 75, Núm. 11

  3. The neutrophil secretome as a crucial link between inflammation and thrombosis

    International Journal of Molecular Sciences, Vol. 22, Núm. 8

2020

  1. Structural and functional basis for understanding the biological significance of p2x7 receptor

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-23

2018

  1. Abacavir induces arterial thrombosis in a murine model

    Journal of Infectious Diseases

2015

  1. Efavirenz and the CNS: What we already know and questions that need to be answered

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 10, pp. 2693-2708

2014

  1. Neuronal bioenergetics and acute mitochondrial dysfunction: A clue to understanding the central nervous system side effects of efavirenz

    Journal of Infectious Diseases, Vol. 210, Núm. 9, pp. 1385-1395

2010

  1. Enhanced oxidative stress and increased mitochondrial mass during Efavirenz-induced apoptosis in human hepatic cells

    British Journal of Pharmacology, Vol. 160, Núm. 8, pp. 2069-2084